v3.25.2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 11, 2025
Sep. 11, 2024
Jun. 17, 2024
Mar. 11, 2024
Nov. 03, 2023
Jul. 27, 2023
Jul. 11, 2023
Jul. 06, 2023
Jul. 05, 2023
Jan. 31, 2023
Jun. 30, 2025
Jun. 30, 2025
Dec. 31, 2024
Loss Contingencies [Line Items]                          
Upfront payment                   $ 150,000      
Milestone payment                   $ 1,000,000      
Payments for research and development       $ 50,000             $ 50,000 $ 100,000  
Accrued expenses                     100,000 100,000  
Chief Executive Officer [Member] | Share-Based Payment Arrangement, Option [Member]                          
Loss Contingencies [Line Items]                          
Grant date fair value                         $ 121,112
Chief Executive Officer [Member] | Maximum [Member] | Share-Based Payment Arrangement, Option [Member]                          
Loss Contingencies [Line Items]                          
Purchase of stock options shares                         80,958
Chief Operating Officer [Member] | Share-Based Payment Arrangement, Option [Member]                          
Loss Contingencies [Line Items]                          
Grant date fair value                         $ 79,100
Chief Operating Officer [Member] | Maximum [Member] | Share-Based Payment Arrangement, Option [Member]                          
Loss Contingencies [Line Items]                          
Purchase of stock options shares                         52,875
ABSI [Member]                          
Loss Contingencies [Line Items]                          
Milestone payment                 $ 8,250,000        
Common stock issued           25,107              
Value of common stock issued           $ 250,000              
Net proceeds                 $ 10,000,000        
Avior Patent License Agreement [Member]                          
Loss Contingencies [Line Items]                          
Milestone payment         $ 24,250,000                
Up front license fee         400,000                
License fee         $ 150,000                
Milestone fees                     0 0  
Enkefalos License Agreement [Member]                          
Loss Contingencies [Line Items]                          
Upfront payment     $ 150,000                    
Milestone fees paid                     $ 0 200,000  
Intract Patent License Agreement (Member)                          
Loss Contingencies [Line Items]                          
Upfront payment   $ 400,000                      
Milestone fees                       $ 150,000  
Restated Employment Agreement [Member] | Chief Executive Officer [Member]                          
Loss Contingencies [Line Items]                          
Salaries and wages               $ 500,000          
Percentage of cash bonus received               60.00%          
Restated Employment Agreement [Member] | Chief Operating Officer [Member]                          
Loss Contingencies [Line Items]                          
Salaries and wages             $ 400,000            
Percentage of cash bonus received             50.00%            
CEO Settlement Agreement [Member] | Chief Executive Officer [Member]                          
Loss Contingencies [Line Items]                          
Gross payments for CEO $ 133,500                        
Financing in debt, equity 3,000,000                        
Chairman Employment Agreement [Member] | Chief Executive Officer [Member]                          
Loss Contingencies [Line Items]                          
Salaries and wages $ 285,000                        
Percentage of cash bonus received 60.00%